Insigneo Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.02M Sell
6,549
-106
-2% -$107K 0.43% 37
2025
Q4
$7.15M Buy
6,655
+504
+8% +$482K 0.51% 28
2025
Q3
$4.69M Buy
6,151
+217
+4% +$161K 0.33% 45
2025
Q2
$4.63M Sell
5,934
-339
-5% -$263K 0.4% 40
2025
Q1
$5.18M Buy
6,273
+777
+14% +$647K 0.53% 27
2024
Q4
$4.24M Sell
5,496
-1,074
-16% -$889K 0.44% 34
2024
Q3
$5.82M Sell
6,570
-430
-6% -$387K 0.59% 20
2024
Q2
$5.43M Buy
7,000
+908
+15% +$726K 0.61% 24
2024
Q1
$4.74M Buy
6,092
+1,455
+31% +$1.04M 0.56% 28
2023
Q4
$2.7M Buy
4,637
+1,512
+48% +$883K 0.38% 50
2023
Q3
$1.68M Buy
3,125
+440
+16% +$227K 0.34% 60
2023
Q2
$1.26M Buy
2,685
+95
+4% +$39.8K 0.24% 90
2023
Q1
$889K Buy
2,590
+284
+12% +$95.8K 0.28% 72
2022
Q4
$844K Buy
+2,306
New +$818K 0.32% 65

Other funds holding LLY

Insigneo Advisory Services's LLY Position: Q1 2026 in Review

Insigneo Advisory Services reduced its Eli Lilly (LLY) stake by 1.6% in Q1 2026, selling an estimated $107K and leaving 6,549 shares worth $6.02M. The position accounts for 0.43% of the portfolio, ranked #37.

Insigneo Advisory Services first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $7.15M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Insigneo Advisory Services held 6,549 shares of Eli Lilly worth $6.02M as of Q1 2026.
  • Insigneo Advisory Services sold 106 Eli Lilly shares in Q1 2026, an estimated $107K.
  • Eli Lilly made up 0.43% of Insigneo Advisory Services's portfolio in Q1 2026, its #37 holding.
  • Insigneo Advisory Services first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • Insigneo Advisory Services's Eli Lilly position peaked at $7.15M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Insigneo Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.